Functional restoration of CD56bright NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B

[1] El-Serag HB(2012)Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 142 e1261-24

[2] Bertoletti A(2010)The host-pathogen interaction during HBV infection: immunological controversies Antivir Ther 15 15-S101

[3] Maini MK(2016)Mechanisms of HBV-induced hepatocellular carcinoma J Hepatol 64 S84-1764

[4] Ferrari C(2012)Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection Gut 61 1754-588

[5] Levrero M(2015)Natural killer cells in viral hepatitis Cell Mol Gastroenterol Hepatol 1 578-216

[6] Zucman-Rossi J(2013)KCTD9 contributes to liver injury through NK cell activation during hepatitis B virus-induced acute-on-chronic liver failure Clin Immunol 146 207-475

[7] Bertoletti A(2010)Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure J Immunol 184 466-3386

[8] Ferrari C(2001)Activation by 9-(R)-[2-(phosphonomethoxy)propyl]adenine of chemokine (RANTES, macrophage inflammatory protein 1alpha) and cytokine (tumor necrosis factor alpha, interleukin-10 [IL-10], IL-1beta) production Antimicrob Agents Chemother 45 3381-218

[9] Rehermann B(2011)Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B J Hepatol 54 209-2588

[10] Chen T(2010)Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection PLoS Pathog 6 e1001227-605

[1] El-Serag HB(2012)Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 142 e1261-24

[2] Bertoletti A(2010)The host-pathogen interaction during HBV infection: immunological controversies Antivir Ther 15 15-S101

[3] Maini MK(2016)Mechanisms of HBV-induced hepatocellular carcinoma J Hepatol 64 S84-1764

[4] Ferrari C(2012)Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection Gut 61 1754-588

[5] Levrero M(2015)Natural killer cells in viral hepatitis Cell Mol Gastroenterol Hepatol 1 578-216

[6] Zucman-Rossi J(2013)KCTD9 contributes to liver injury through NK cell activation during hepatitis B virus-induced acute-on-chronic liver failure Clin Immunol 146 207-475

[7] Bertoletti A(2010)Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure J Immunol 184 466-3386

[8] Ferrari C(2001)Activation by 9-(R)-[2-(phosphonomethoxy)propyl]adenine of chemokine (RANTES, macrophage inflammatory protein 1alpha) and cytokine (tumor necrosis factor alpha, interleukin-10 [IL-10], IL-1beta) production Antimicrob Agents Chemother 45 3381-218

[9] Rehermann B(2011)Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B J Hepatol 54 209-2588

[10] Chen T(2010)Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection PLoS Pathog 6 e1001227-605